KBO Systems

Cover Block

Name	KBO Systems
Tagline	AI-driven perioperative brain health and sedation monitoring platform for hospitals.
Founded	2023
Stage	Pre-Seed
Business Model	B2B
Industry	Healthtech
Technology	AI / Machine Learning
Geography	North America
Growth Profile	Venture Scale
Founding Team	Co-Founders (2)

Links

• Website: https://kbosystems.com/
• LinkedIn: https://www.linkedin.com/company/kbo-systems

Executive Summary

KBO Systems is a pre-revenue medical device startup developing an AI-driven platform for perioperative brain health and sedation monitoring, targeting a clinical problem estimated to cost $155 billion annually [Thunderview CEO Dinners, 2026]. The company's core proposition is to translate non-invasive electrophysiological signals, primarily EEG and AEP data, into real-time guidance for anesthesia management and cognitive recovery prediction, aiming to reduce complications in older and high-risk surgical patients [Perplexity Sonar Pro Brief] [Tracxn]. Founded in 2023 by Kevin Goehl and Rocky Cagle, the venture is in its earliest stages, with no institutional funding rounds or named customer deployments yet publicly confirmed [Tracxn] [Crunchbase]. The business model is B2B, targeting hospital systems, and the company is associated with the Medical Technology Enterprise Consortium (MTEC), suggesting engagement with defense-related health research channels [Connects Workspace, 2026]. Over the next 12-18 months, the key milestones to watch are the securing of seed funding to advance product development, the initiation of clinical validation studies, and the announcement of a first hospital pilot or partnership.

Data Accuracy: YELLOW -- Core product claims are consistent across multiple directories, but funding status and team details rely on single or partial sources.

Taxonomy Snapshot

Axis	Value
Stage	Pre-Seed
Business Model	B2B
Industry / Vertical	Healthtech
Technology Type	AI / Machine Learning
Geography	North America
Growth Profile	Venture Scale
Founding Team	Co-Founders (2)

How the Company Got Here

KBO Systems was founded in 2023 as a medical device technology company focused on perioperative brain health [Sesamers]. The company's stated mission is to change the landscape of perioperative monitoring by developing advanced signal processing algorithms to provide clinicians with more useful tools [Perplexity Sonar Pro Brief]. The founding team consists of two co-founders, Kevin Goehl and Rocky Cagle [Tracxn]. Goehl is identified as the CEO [Prospeo].

The company is developing its platform in Sacramento, California, according to a company directory [Prospeo]. Public records show a separate UK entity named KBO SYSTEMS LTD, registered to a different principal, which appears to be unrelated to the US-based health-tech startup [Perplexity Sonar Pro Brief]. KBO Systems is listed as a member of the Medical Technology Enterprise Consortium (MTEC), a public-private partnership focused on medical technology development, which represents its most visible external affiliation [Perplexity Sonar Pro Brief].

Data Accuracy: YELLOW -- Founding year and team composition are cited by multiple directories; headquarters and MTEC association are from single sources.

Product and Technology

KBO Systems is building a medical device platform that translates raw electrophysiological signals into real-time cognitive assessments for surgical patients. The company's core offering, described as the Perioperative Brain Health Platform, aims to provide clinicians with a continuous, non-invasive readout of a patient's brain state before, during, and after anesthesia. The system ingests data from standard hospital monitoring equipment, primarily electroencephalogram (EEG) and auditory evoked potential (AEP) signals, and applies proprietary signal-processing algorithms and machine learning models to generate insights [KBO Systems] [Tracxn].

The platform surfaces two specific applications. The first is personalized anesthesia management, where the AI-driven analysis is designed to help anesthesiologists titrate sedative and paralytic drugs more precisely based on an individual patient's real-time neurological response [Prospeo]. The second is risk prediction, where the system analyzes perioperative data to forecast a patient's likelihood of experiencing postoperative cognitive dysfunction or a delayed recovery [Perplexity Sonar Pro Brief]. A specific product concept named in external profiles is PASS, or the Paralytic and Sedation System. This appears to be a dedicated module within the broader platform, described as a medical device incorporating an AI learning model for predictive monitoring and large-scale data analysis to guide hospital physicians [Tracxn].

The market for perioperative brain monitoring is gaining urgency as healthcare systems seek to reduce the high costs and poor outcomes associated with postoperative cognitive complications. The company has cited the problem of monitoring sedation and paralytic medications as a $155 billion annual challenge [Thunderview CEO Dinners, 2026].

Metric	Value
Sedation/Paralytic Monitoring Problem (cited)	$155B
Patient Monitoring Devices (2023)	$39.5B
Intraoperative Neuromonitoring (2022)	$1.8B

Data Accuracy: YELLOW -- The $155B figure is a single-source claim; adjacent market sizes are from third-party analyst reports.

Competitive Landscape

KBO Systems enters a market defined by established medical device giants and a growing field of digital health startups, with its differentiation resting on a specific integration of brain health monitoring with anesthesia management. The competitive map for perioperative monitoring is stratified. At the top are incumbent medical device conglomerates like Medtronic and GE HealthCare, which offer comprehensive anesthesia workstations and patient monitoring suites. A layer of specialized neurology monitoring companies, such as Natus Medical or Cadwell Laboratories, provide advanced EEG and neuromonitoring equipment. The most direct competitive pressure comes from a growing cohort of digital health and AI startups targeting perioperative intelligence.

KBO's claimed edge today is technological and clinical focus. The company's wedge is the fusion of proprietary signal processing algorithms applied to EEG/AEP data to generate real-time guidance for anesthesia dosing, specifically tied to cognitive recovery risks [KBO Systems] [Perplexity Sonar Pro Brief]. The association with the Medical Technology Enterprise Consortium (MTEC) provides a channel for early clinical validation and potential government-funded development paths [MTEC].

If KBO Systems successfully commercializes its AI-driven brain monitoring platform, the prize is a dominant position in a clinical workflow that currently costs the U.S. healthcare system an estimated $155 billion annually [Thunderview CEO Dinners, 2026].

Scenario	What happens	Catalyst	Why it's plausible
MTEC-Funded Clinical Validation	KBO secures a funded research contract through MTEC, leading to a multi-site clinical study validating its platform's efficacy in reducing postoperative cognitive decline.	Award of a formal MTEC Other Transaction Authority (OTA) agreement for prototype development and testing.	MTEC's portfolio explicitly lists KBO Systems and describes its technology, indicating an existing relationship and a potential path to non-dilutive funding and clinical access [MTEC].
Strategic Partnership with a Major MedTech	A large anesthesia or patient monitoring company (e.g., GE Healthcare, Medtronic) licenses or co-develops KBO's AI algorithms for integration into their existing hospital monitoring suites.	Announcement of a development or licensing partnership with a named industry player.	The company's focus on a niche, high-value data layer (brain state) makes it an attractive bolt-on for established hardware vendors seeking AI differentiation.
Direct Commercial Launch in ASCs	KBO targets ambulatory surgery centers (ASCs) first, where faster patient turnover and lower acuity could allow for quicker adoption of a new monitoring system focused on efficiency and recovery.	First commercial sale to a named ASC chain or independent surgical facility.	ASCs are often early adopters of cost-saving, workflow-enhancing technologies, and a focused launch in this segment could provide initial revenue and clinical proof points.

Data Accuracy: YELLOW -- The core market sizing claim is cited, but growth scenarios and compounding dynamics are inferred from the company's stated technology focus and common industry patterns.

Sources

1. [Thunderview CEO Dinners, 2026] The Kevin Sheehan Show | https://open.spotify.com/show/0SYDzK54PmNWjmCYt2GWRv
2. [Perplexity Sonar Pro Brief] KBO Systems Brief |
3. [Tracxn] KBO Systems - 2026 Company Profile, Team & Competitors | https://tracxn.com/d/companies/kbosystems/__nU-ogZ0iB6QnrLxFDSdW1MC-NXlSI27n9JJhgWiDnpU
4. [Crunchbase] KBO Systems - Crunchbase Company Profile & Funding | https://www.crunchbase.com/organization/kbo-systems
5. [LinkedIn] KBO Systems LinkedIn Profile | https://www.linkedin.com/company/kbo-systems
6. [Prospeo] KBO Systems Overview, Address & Contact | https://prospeo.io/c/kbo-systems
7. [Sesamers] KBO Systems - Sesamers | https://sesamers.com/startups/kbo-systems
8. [KBO Systems] KBO Systems Website | https://kbosystems.com/
9. [Connects Workspace, 2026] Company Interviews - Podcast | https://podcasts.apple.com/us/podcast/company-interviews/id1462096731
10. [Grand View Research, 2023] Patient Monitoring Devices Market Size Report |
11. [MarketsandMarkets, 2022] Intraoperative Neuromonitoring Market Report |
12. [MTEC] Medical Technology Enterprise Consortium Portfolio |